Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Current assets
Cash and cash equivalents	$ 230,259	$ 235,136
Receivables - net	252,845	213,553
Inventories	254,258	196,546
Other current assets	51,799	47,523
Total current assets	789,161	692,758
Property, plant and equipment - net	213,717	188,562
Goodwill	1,431,366	1,207,001	[1]
Intangible assets - net	382,222	281,392
Other noncurrent assets	19,641	11,982
Total assets	2,836,107	2,381,695
Current liabilities
Trade accounts payable	110,977	104,055
Accrued expenses	130,696	117,879
Short-term borrowings	2,444	119,445
Dividends payable	14,161	12,289
Total current liabilities	258,278	353,668
Long-term borrowings	806,366	408,450
Deferred income taxes	142,482	148,534
Other noncurrent liabilities	115,846	95,383
Total liabilities	1,322,972	1,006,035
Commitments and contingencies (Note 8)
Preferred stock:
Authorized: 5,000,000 shares, $.01 per share par value; Issued: none
Common stock:
Authorized: 150,000,000 shares, $.01 per share par value; Issued: 85,968,630 shares at December 31, 2011 and 84,636,668 shares at December 31, 2010	860	846
Additional paid-in capital	490,128	441,271
Retained earnings	1,142,412	1,005,040
Treasury stock at cost: 2,734,747 shares at December 31, 2011 and 2,566,985 shares at December 31, 2010	(64,796)	(58,788)
Accumulated other comprehensive loss	(55,469)	(12,709)
Total shareholders' equity	1,513,135	1,375,660
Total liabilities and shareholders' equity	$ 2,836,107	$ 2,381,695

[1] Revised to reflect the movement of the MPT reporting unit from the Fluid & Metering Technologies segment to the Health & Science Technologies segment.